Ai-Assisted Conversational Support To Facilitate Neuroadaptation After Bilateral Trifocal Intraocular Lens Implantation: A Prospective Observational Study
Published 2026 - 44th Congress of the ESCRS
Reference: FP01.07 | Type: Free paper | DOI: 10.82333/yc4b-bj05
Authors: Prof. Dr Biljana Kostovska* 1 , Prof. Dr Gad Segal 2 , Dr Rivka Rosenberg 2
1Sistina Ophthalmology, Promedika,Skopje,North Macedonia;Faculty of Medical Sciences, Goce Delcev University,Stip,North Macedonia, 2Sheba Medical Center,Ramat Gan,Israel
Purpose
Although contemporary trifocal intraocular lenses (IOLs) provide excellent refractive accuracy and visual outcomes, postoperative dissatisfaction may still occur due to dysphotopsia-related symptoms such as halos, glare, and contrast sensitivity changes. These symptoms often trigger anxiety-driven communication and additional clinical visits despite optimal refractive results. This study evaluates the clinical and operational impact of an AI-assisted conversational support system designed to normalize dysphotopsia perception and support neuroadaptation following bilateral trifocal IOL implantation.
Setting
Implementation study of AI-assisted postoperative support in bilateral trifocal IOL surgery.
Methods
In this prospective observational study 50 consecutive patients(100 eyes)undergoing bilateral trifocal IOL implantation were enrolled.25 patients received Clareon PanOptix and 25 received PanOptix.Preoperative spherical equivalent ranged from –5.00D to +5.00D with refractive cylinder ≤ –2.50D.From postoperative day 1 patients accessed an AI-guided conversational platform providing dysphotopsia normalization, adaptive reassurance, and structured daily symptom monitoring.Primary endpoints were unscheduled postoperative visits and anxietydriven communication.Secondary endpoints included subjective neuroadaptation time and patient satisfaction.Outcomes were compared with historical matched multifocal IOL cohorts managed with standard counseling
Results
On postoperative day 1, 91% of eyes (95% CI: 85.4–96.6%) achieved functional distance acuity (20/25–20/20). At 1 month, 95% achieved 20/20 distance acuity, increasing to 98% at 3 months, with the same proportion achieving J1+ near vision. No eye had visual acuity worse than 20/25 and no secondary interventions were required. Seventy-three percent of eyes were within ±0.50 D and 93% within ±0.75 D of target; 100% had postoperative cylinder ≤0.75 D. A trend toward approximately 20% higher night-driving satisfaction was observed with Clareon PanOptix. Compared with historical controls, unscheduled visits decreased from 22% to 8% (64% reduction during the first postoperative month).
Conclusions
Even with excellent objective visual outcomes perception-driven dissatisfaction remains relevant after trifocalIOL implantation.AI-assisted conversational normalization may reduce anxietydriven healthcare utilization while supporting neuroadaptation without compromising refractive performance.observed reduction in unnecessary reassurance visits suggests potential operational benefits.Approach may be particularly relevant for younger presbyopic patients with high visual expectations and may assist ophthalmologists in optimizing clinical time, reducing postoperative dissatisfaction and integrating structured telemedicine into routine postoperative care. Further controlled studies are warranted to confirm longterm clinical and workflow impact.